EL7.AI
Strategy BuilderCOT DataAdvanced NewsResearchNewEarnings CalendarEconomic Calendar
We use cookiesPrivacy Policy
EL7.AIEL7.AI

AI Financial Intelligence
Professional analysis of central bank decisions

© 2026 EL7.AI. All rights reserved.

Markets

  • News
  • Forex
  • Stocks
  • Crypto
  • Gold
  • Commodities
  • Indices
  • ETFs

Analysis

  • Fed
  • ECB
  • BLS
  • COT
  • Economic Calendar

Learn

  • Service Guide
  • Oil

Company

  • About
  • Contact
  • Data Methodology
  • AI Disclosure
  • Pricing
  • Enterprise
  • Terms
  • Privacy
  • Security
  • WhatsApp
Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Home
Stocks
Everus Construction Group, Inc.
ECG

ECG Everus Construction Group, Inc.

Everus Construction Group, Inc. · NYSE
Market Closed
119.42
▲ ⁦+3.64%⁩ (+4.19)
Market Cap$6.1B
Beta2.47
52w Low52w High
73.00171.58
Last Week
⁦+5.95%⁩
Last Month
⁦-12.76%⁩
Last 3 Months
⁦-20.79%⁩
Last Year
⁦+52.24%⁩
EL7 Factor Analysis
How we score this
Overall64
Balanced — near the middle of the marketHigh FlyerF 6/9Better than 64% of Market stocks, per EL7's model
FactorScoreDistributionValueAvgRank
▸
Valuation
45
24.0x▼17.8xAround median
▸
Growth
20
-18.1%▼7.1%Bottom tier
▸
Quality
69
24.0%▲4.5%Top tier
▸
Safety
78
0.5x▲2.6xTop tier
▸
Capital Return
51
—2.12%Around median
▸
Momentum
53
73.7%▲2.9%Around median
▸
Sentiment
74
4▲3Top tier
Fair Value
Low confidenceCurrent price$119
Analyst target · 1 analysts
$170
⁦+42%⁩
See it clearly undervalued
Range ⁦$141–$200⁩
vs
DCF (estimate)
$41
⁦-66%⁩
Sees it clearly overvalued
⁦13.3⁩% discount · ⁦2⁩% growth
Bottom lineThe two methods disagree — estimate range ⁦$41–$170⁩.

Estimates — analyst targets and a simplified DCF, not investment advice.

Compare in the screener
Premium content

Get Your Premium Account Now

  • Stock Deep Analysis
  • The Advanced News Platform
Recommended
Annual plan
$17/mo
Monthly plan
$29/mo

Analyst Consensus

This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.

Price Target· 1 analysts setting price target
$169.50
⁦+41.9%⁩
Current Price $119.42·Median $170.00
Low
$141.00
High
$200.00
Current price
$119.42
Average target
$169.50
Street summary

Price Target Update for Everus Construction Group (ECG) Stock

Bullish tilt

The stock has seen a notable positive revision in its average price target, rising from 153.6 to 169.8 over the past thirty days, an increase of 10.55%. This trend reflects growing optimism, especially as the current price (137.5) is trading below the lowest price target set by analysts (141), indicating a positive price gap.

As of 2026-08-13
Revisions momentum · 30d
⁦+4.4%⁩
Average rating
★ 3.71
Buy
Analyst coverage
7
Buy conviction
71%
High
Target dispersion
49%
Wide
Analyst ratings over time7 analysts rating
5
2
Strong BuyBuyHoldSellStrong Sell
Rating trend — last 12 months3.57 → 3.71
Recent analyst moves
  • = Reiterate2026-08-06
    Guggenheim
    Buy
  • = Reiterate2026-08-06
    Oppenheimer
    Outperform
  • = Reiterate2026-05-08
    Stifel Nicolaus
    —· $172.00
Premium content
Key Financials

Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.

StockSector medianSector averagetypical sector range
MetricValuePosition within sectorVerdict
  • P/E (TTM)
    24.03x
    5.69x45.54x
    Near median
  • Forward P/E
    25.06x
    4.57x36.58x
    Above average
  • EV / EBITDA
    17.78x
    3.43x27.47x
    Near median
  • FCF Yield
    4.1%
    -32.7%11.5%
    Strong
  • Revenue Growth YoY
    -18.1%
    -10.7%43.4%
    Weak
  • EPS Growth YoY
    -1.0%
    -128.3%132.7%
    Near median
  • Gross Margin
    13.0%
    8.6%54.6%
    Weak
  • ROIC
    24.0%
    -25.3%19.6%
    Exceptional
  • Net Debt / EBITDA
    0.53x
    0.55x4.37x
    Low debt
  • Dividend Yield
    —
    —
  • Payout Ratio
    —
    —
  • Altman Z-Score
    —
    —
Financial Analysis
|

Stock Analysis

AI-generated
Based on 2026-08-05 data

Company Overview

Everus Construction Group operates through two primary businesses: Electrical & Mechanical E&M and Transmission & Distribution T&D. The company derives revenue from executing commercial, industrial, and utility infrastructure projects, including data centers, semiconductor plants, healthcare, renewable energy, and hospitality, and it also uses modular construction and prefabrication to improve labor and material efficiency and increase execution predictability. In Q2 fiscal 2026, the E&M segment accounted for approximately $1.01 billion of revenue, compared with $227.5 million for the T&D segment, illustrating the business mix’s heavy dependence on electrical and mechanical operations.

Everus reported record revenue of $1.23 billion in Q2 fiscal 2026, up 34% year over year, including 30% organic growth excluding the contribution from SE&M. EBITDA reached $128.6 million, up 53%, and its margin increased to 10.4% from 9.1%, while earnings per share reached $1.64, exceeding expectations by 44%. At the segment level, E&M revenue increased 42% and its EBITDA margin rose to 10.8% from 8.9%, while T&D revenue grew 7.1% and its margin remained nearly stable at 14.4% versus 14.3%.

The latest available EDGAR filings show a broader earnings base ahead of the Q2 fiscal 2026 results; revenue for the twelve months ending in fiscal 2026 was approximately $4.0 billion, gross profit was $492.3 million, and net income was $223.4 million. By comparison, the company generated fiscal 2025 revenue of $3.7 billion, gross profit of $454.1 million, and net income of $201.8 million, with earnings per share of $3.95. Q1 fiscal 2026 also showed revenue of $1.0 billion, net income of $58.3 million, and earnings per share of $1.14.

What's Driving the Stock

  • Backlog reached $4.55 billion on June 30, 2026, up 53% year over year according to the earnings call, with E&M backlog growing 62% and SE&M contributing approximately $100 million; management also expects to execute approximately 80% of total backlog within 12 months.
Earnings callEDGAR filings30-day newsInsider activity

Automated analysis for informational purposes only — not investment advice.

  • On August 5, 2026, management raised its fiscal 2026 guidance to revenue of between $4.5 billion and $4.7 billion and EBITDA of between $410 million and $425 million, citing the strength of the first half and continued demand and execution momentum.
  • Data centers are driving a significant portion of demand and are the largest component of backlog, with work concentrated among several hyperscale computing operator customers; at the same time, management said backlog increased sequentially across most end markets and that the majority of the quarterly increase did not come from the commercial market.
  • The E&M segment generated organic growth of 37% in Q2 fiscal 2026 excluding SE&M, and its EBITDA increased 72% to $109.3 million due to revenue growth, improved gross margin, project timing, and execution quality.
  • The company completed the acquisition of SE&M in April 2026, and integration was proceeding according to plan as of August 5, 2026, while the announced acquisition of Epsilon Industries was expected to close later in fiscal 2026. Epsilon adds more than 50 engineers and 120 skilled workers, along with capabilities in custom design, manufacturing, and field installation for projects such as data centers, advanced manufacturing, and healthcare.
  • Operating cash flow in the first six months of fiscal 2026 jumped to $196.8 million from $32.5 million, and free cash flow increased to $167 million from $6.5 million, supporting investment and acquisitions while net leverage remained at 0.3 times on June 30, 2026.
  • Buying & Selling Case

    ▲ Buying Case4 pts

    • +Q2 fiscal 2026 combined revenue growth of 34% with EBITDA growth of 53%, reflecting operating profit growth faster than revenue and margin expansion of 130 basis points.
    • +The $4.55 billion backlog, approximately 80% of which is expected to be executed within 12 months, provides strong revenue visibility, while management reported on August 5, 2026 that there had been no project cancellations or notable changes in customer activity.
    • +Expansion does not depend entirely on acquisitions; the group’s organic revenue grew 30%, and organic E&M revenue grew 37% in Q2 fiscal 2026, alongside demand from data centers, semiconductors, and other end markets.
    • +Liquidity and the balance sheet give the company room to continue growing; on June 30, 2026, it had $157 million of unrestricted cash and $223 million available under its credit facility, with net leverage of only 0.3 times compared with the target range of between 1.5 and 2.0 times.

    ▼ Selling Case6 pts

    • −Data centers represent the largest portion of backlog, and work in this area is concentrated among several hyperscale computing operator customers; therefore, slower spending by a limited number of these customers could affect E&M segment growth even as operations expand across other regions and markets.
    • −Management’s guidance assumes an EBITDA margin of approximately 8.5% in the second half of fiscal 2026, below the 10.4% margin recorded in Q2 and the expected full-year margin of approximately 9%, indicating that first-half margin strength will not continue at the same level under management’s base-case scenario.
    • −Management describes the market as cyclical and maintained its long-term targets of organic revenue growth of between 5% and 7% and an EBITDA compound annual growth rate of between 7% and 9% over a horizon exceeding five years; these rates are far below the 30% organic revenue growth in Q2 fiscal 2026, supporting the possibility that growth will slow after the current strong conditions.
    • −Part of the expansion is linked to integrating SE&M, completing the Epsilon transaction, and geographically expanding modular construction capabilities; Epsilon’s contribution was excluded from fiscal 2026 guidance as of August 5, 2026, so closing the transaction and converting cross-selling and geographic expansion opportunities into actual results remain execution factors to monitor.
    • −Analysts’ price targets range from $141 to $200, a wide $59 range that reflects a meaningful divergence in estimates of the company’s value, while the average target of $169.5 is very close to the 52-week range high of $171.577; this increases valuation sensitivity to any failure to meet guidance or slowdown in backlog.
    • −Insider activity was neutral during the three months ending in August 2026, with one purchase and one sale and net activity of negative $306,127.33, and the latest transaction occurred on August 17, 2026. This remains a weak standalone signal because insider sales may be prearranged and are not sufficient on their own to assess the company’s prospects.

    Valuation

    The analyst consensus on ECG stock is “Buy,” with an average price target of $169.5, a high of $200, and a low of $141. The average target is slightly below the 52-week range high of $171.577, while the highest target exceeds that high and the lowest target remains well above the range low of $73; however, the wide gap between the lowest and highest targets reflects significant disagreement about the sustainability of growth and margins. A price-to-earnings ratio is not available in the data, so the stock’s valuation here is based on the target range, the 52-week range, and the company’s ability to achieve its fiscal 2026 guidance.

    BuyAnalyst target: $169.5(+41.9%)

    Figures in the text are as of 2026-08-30; the live price is shown at the top of the page.

    FAQ

    What is driving growth for Everus and its ticker ECG in fiscal 2026?

    The E&M segment led performance in Q2 fiscal 2026, with revenue increasing 42% to $1.01 billion, or 37% organically excluding SE&M. Data centers were the largest component of backlog, alongside growth in business related to semiconductors and the industrial, institutional, and utility end markets. Total backlog reached $4.55 billion on June 30, 2026, up 53% year over year, with approximately 80% expected to be executed within 12 months.

    What is Everus’s guidance for fiscal 2026?

    On August 5, 2026, management raised its expected fiscal 2026 revenue range to between $4.5 billion and $4.7 billion. It also raised its EBITDA range to between $410 million and $425 million, implying a margin of approximately 9% at the midpoint. This guidance does not include any contribution from Epsilon, while it assumes a margin of approximately 8.5% in the second half of fiscal 2026.

    How do SE&M and Epsilon affect ECG’s growth story?

    Everus completed the acquisition of SE&M in April 2026, and the acquired company contributed approximately $100 million to backlog at the end of Q2 fiscal 2026. On August 5, 2026, management said the integration of SE&M was proceeding according to plan and that it was exploring expanded opportunities related to the business. Epsilon adds off-site modular construction capabilities, more than 50 engineers, and 120 skilled workers, with a presence supporting expansion in Florida, Texas, the Mid-Atlantic, and the Northeast, and the transaction was expected to close later in fiscal 2026.

    Can Everus’s balance sheet fund further growth?

    On June 30, 2026, Everus had $157 million of unrestricted cash and total debt of $278 million, in addition to $223 million available under its credit facility. Net debt to EBITDA was 0.3 times, well below the target range of between 1.5 and 2.0 times. The company also generated free cash flow of $167 million in the first six months of fiscal 2026, although management noted that working capital timing supported part of this performance.

    What are the main investment risks for ECG?

    The greatest concentration comes from data centers, which are the largest component of backlog, with part of the work performed for several hyperscale computing operator customers. Management also expects the EBITDA margin to decline to approximately 8.5% in the second half of fiscal 2026, compared with 10.4% in Q2. In addition, management described the market as cyclical and set long-term organic revenue growth at between 5% and 7%, meaning that the 30% organic growth rate in Q2 fiscal 2026 is not an appropriate long-term assumption.

    What is the analyst outlook for ECG stock?

    The analyst consensus is “Buy,” and the average price target is $169.5. Targets range from $141 to $200, a $59 spread that reflects clear divergence in valuation estimates. The average target is close to the 52-week range high of $171.577, while the stock’s full 52-week range extends from $73 to $171.577.